Betterchem
Health     Drug Information     DMFs     Portal     21CFR     Search     Site Map

 

[search the news]  
 

Health and Pharmaceutical News Archive

 
                                                                   

 
Search our news archive and pharma companies…

Today's News | Note: News feeds may no longer be available for the articles on this page.

Wyeth bone drug reduced fractures in longer study 8:18 AM 9/15/2009
Forbes
Wyeth said women who took its osteoporosis drug candidate bazedoxifene had a lower risk of new fractures to their vertebrae. ...

Speedier Vaccine Access Raises Odds Swine Flu May Be Controlled 4:52 AM 9/15/2009
Bloomberg
Single-dose vaccine and manufacturing improvements could help the world inoculate 3 billion people. Perception that vaccine is experimental makes some parents reluctant to have children immunized. ...

Novartis Drug Improves Lung Function, Reduces Breathlessness 3:33 AM 9/15/2009
Wall Street Journal
Swiss drug maker Novartis AG said its experimental respiratory drug QAB149 improved lung function and reduced breathlessness in a late-stage trial. ... ...

FDA wants more information on Centocor cancer drug Trabectedin 2:33 PM 9/14/2009
Bizjournals.com
Centocor Ortho Biotech subsidiary of Johnson & Johnson seeks US FDA approval for Trabectedin to be administered in combination with Doxil to treat women with relapsed ovarian cancer. The agency requested overall survival data and additional clinical pharmacology studies. ...

Myriad Drug Reduces HIV as Much as 50-Fold in Study 1:44 PM 9/14/2009
Bloomberg
Myriad Pharmaceuticals Inc’s experimental AIDS drug bevirimat dimeglumine cut the virus as much as 50-fold in two weeks. Maturation inhibitors prevent the virus from developing into a form capable of infecting other healthy cells. ...

FDA staff weighs Auxilium hand disorder drug 10:41 AM 9/14/2009
Reuters
The US FDA says Auxilium Pharmaceuticals Inc's data show experimental drug Xiaflex for patients with potentially crippling hand disorder appears to provide some relief. ...

 

 

Alexza migraine drug fails to meet goal in study 7:19 AM 9/14/2009
Reuters
Alexza Pharmaceuticals said preliminary results from a mid-stage trial of migraine drug AZ-104 did not meet the primary goal of headache pain-relief at two hours post-dose. ...

Ariad says independent experts positive on cancer drug 6:49 AM 9/14/2009
Reuters
An independent committee of experts recommended that a late-stage trial of Ariad Pharmaceuticals Inc's experimental cancer treatment ridaforolimus may continue. ...

GTx says committee positive on cancer drug trial 6:28 AM 9/14/2009
Reuters
GTx Inc said an independent data safety monitoring committee recommended continuation of late-stage trials of toremifene for the prevention of prostate cancer. ...

Salix Pharma's bowel drug meets late-stage goals 5:58 AM 9/14/2009
Reuters
Salix Pharmaceuticals said its drug Rifaximin met the main goal of late-stage studies providing adequate relief from symptoms of irritable bowel syndrome. ...

Swine Flu Shots to Start in Three Weeks as US Cases Spread 12:39 PM 9/13/2009
Bloomberg
Test results boost hopes the vaccine may be available in time to curb the first pandemic in 41 years. No serious side effects have been reported in trials too small to detect rare conditions. ...

Parents weigh the risk of vaccinating children for H1N1 7:48 AM 9/12/2009
Los Angeles Times
Tests on the H1N1 vaccines in development aren't completed. Sounds like a formula for unforeseen problems down the road. ...

Regeneron, Sanofi drug fails against pancreatic cancer 3:42 PM 9/11/2009
Reuters
Sanofi-Aventis and Regeneron Pharmaceuticals said they had halted the trial of aflibercept for treatment of pancreatic cancer. It was not effective. Phase III trials of aflibercept will continue against metastatic colorectal, metastatic prostate, and non-small cell lung cancers. ...

FDA approves clinical testing for GenSpera's oncology drug 12:31 PM 9/11/2009
Bizjournals.com
Cancer drug developer GenSpera Inc received FDA approval to proceed with human trials on its investigational cancer drug G-202. ...

New data shows (sic) promise of German Merck's MS drug 11:03 AM 9/11/2009
Reuters
Phase III trial data now show a short course of cladribine tablets significantly increased the proportion of patients without disease activity after two years. And, yes, data is plural. ...

<- Day Earlier | Today's News


 

FindingHealthOnline | Drug Thesaurus | Brand Names | Generic Names | News Digests | For Industry

You may search any of the key words from this page using the search window at the top.

© 2012 Betterchem.com